These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35837722)

  • 1. Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 - implications for retinal screening in HSN1.
    Rodrigues FG; Pipis M; Heeren TFC; Fruttiger M; Gantner M; Vermeirsch S; Okada M; Friedlander M; Reilly MM; Egan C
    J Peripher Nerv Syst; 2022 Sep; 27(3):215-224. PubMed ID: 35837722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
    Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
    N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family.
    Wilson LMQ; Saba S; Li J; Prasov L; Miller JML
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary sensory and autonomic neuropathy type IC accompanied by upper motor neuron abnormalities and type II juxtafoveal retinal telangiectasias.
    Triplett J; Nicholson G; Sue C; Hornemann T; Yiannikas C
    J Peripher Nerv Syst; 2019 Jun; 24(2):224-229. PubMed ID: 30866134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy.
    Dawkins JL; Brahmbhatt S; Auer-Grumbach M; Wagner K; Hartung HP; Verhoeven K; Timmerman V; De Jonghe P; Kennerson M; LeGuern E; Nicholson GA
    Neuromuscul Disord; 2002 Oct; 12(7-8):656-8. PubMed ID: 12207934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions.
    Clark AJ; Kugathasan U; Baskozos G; Priestman DA; Fugger N; Lone MA; Othman A; Chu KH; Blesneac I; Wilson ER; Laurà M; Kalmar B; Greensmith L; Hornemann T; Platt FM; Reilly MM; Bennett DL
    Cell Rep Med; 2021 Jul; 2(7):100345. PubMed ID: 34337561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.
    Davidson G; Murphy S; Polke J; Laura M; Salih M; Muntoni F; Blake J; Brandner S; Davies N; Horvath R; Price S; Donaghy M; Roberts M; Foulds N; Ramdharry G; Soler D; Lunn M; Manji H; Davis M; Houlden H; Reilly M
    J Neurol; 2012 Aug; 259(8):1673-85. PubMed ID: 22302274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
    Rotthier A; Penno A; Rautenstrauss B; Auer-Grumbach M; Stettner GM; Asselbergh B; Van Hoof K; Sticht H; Lévy N; Timmerman V; Hornemann T; Janssens K
    Hum Mutat; 2011 Jun; 32(6):E2211-25. PubMed ID: 21618344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I.
    Dawkins JL; Hulme DJ; Brahmbhatt SB; Auer-Grumbach M; Nicholson GA
    Nat Genet; 2001 Mar; 27(3):309-12. PubMed ID: 11242114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy.
    Suriyanarayanan S; Auranen M; Toppila J; Paetau A; Shcherbii M; Palin E; Wei Y; Lohioja T; Schlotter-Weigel B; Schön U; Abicht A; Rautenstrauss B; Tyynismaa H; Walter MC; Hornemann T; Ylikallio E
    Neuromolecular Med; 2016 Mar; 18(1):81-90. PubMed ID: 26573920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
    Hines TJ; Tadenev ALD; Lone MA; Hatton CL; Bagasrawala I; Stum MG; Miers KE; Hornemann T; Burgess RW
    J Anat; 2022 Nov; 241(5):1169-1185. PubMed ID: 34875719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPTLC1 is mutated in hereditary sensory neuropathy, type 1.
    Bejaoui K; Wu C; Scheffler MD; Haan G; Ashby P; Wu L; de Jong P; Brown RH
    Nat Genet; 2001 Mar; 27(3):261-2. PubMed ID: 11242106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and Molecular Characterization of New
    Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment.
    Fiorillo C; Capodivento G; Geroldi A; Tozza S; Moroni I; Mohassel P; Cataldi M; Campana C; Morando S; Panicucci C; Pedemonte M; Brolatti N; Siliquini S; Traverso M; Baratto S; Debellis D; Magri S; Prada V; Bellone E; Salpietro V; Donkervoort S; Gable K; Gupta SD; Dunn TM; Bönnemann CG; Taroni F; Bruno C; Schenone A; Mandich P; Nobbio L; Nolano M
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12842. PubMed ID: 35904184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells.
    Dedov VN; Dedova IV; Merrill AH; Nicholson GA
    Biochim Biophys Acta; 2004 Mar; 1688(2):168-75. PubMed ID: 14990347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent de novo
    Syeda SB; Lone MA; Mohassel P; Donkervoort S; Munot P; França MC; Galarza-Brito JE; Eckenweiler M; Asamoah A; Gable K; Majumdar A; Schumann A; Gupta SD; Lakhotia A; Shieh PB; Foley AR; Jackson KE; Chao KR; Winder TL; Catapano F; Feng L; Kirschner J; Muntoni F; Dunn TM; Hornemann T; Bönnemann CG
    J Neurol Neurosurg Psychiatry; 2024 Jan; 95(2):103-113. PubMed ID: 38041679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype.
    Auer-Grumbach M; Bode H; Pieber TR; Schabhüttl M; Fischer D; Seidl R; Graf E; Wieland T; Schuh R; Vacariu G; Grill F; Timmerman V; Strom TM; Hornemann T
    Eur J Med Genet; 2013 May; 56(5):266-9. PubMed ID: 23454272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of SPTLC1-related disorders: a novel case of 'Ser331 syndrome' that expand the phenotype of hereditary sensory and autonomic neuropathy type 1A and motor neuron diseases.
    Lorenzoni PJ; Bayer DL; Ducci RD; Fustes OJH; do Vale Pascoal Rodrigues PR; Werneck LC; Kay CSK; Scola RH
    Neurol Sci; 2023 Jul; 44(7):2551-2554. PubMed ID: 36964315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis.
    Bejaoui K; Uchida Y; Yasuda S; Ho M; Nishijima M; Brown RH; Holleran WM; Hanada K
    J Clin Invest; 2002 Nov; 110(9):1301-8. PubMed ID: 12417569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.